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A B S T R A C T
In Trypanosoma cruzi, the causal agent of Chagas disease, the first seven steps of glycolysis are compartmenta-
lized in glycosomes, which are authentic but specialized peroxisomes. Besides glycolysis, activity of enzymes of
other metabolic processes have been reported to be present in glycosomes, such as β-oxidation of fatty acids,
purine salvage, pentose-phosphate pathway, gluconeogenesis and biosynthesis of ether-lipids, isoprenoids,
sterols and pyrimidines. In this study, we have purified glycosomes from T. cruzi epimastigotes, collected the
soluble and membrane fractions of these organelles, and separated peripheral and integral membrane proteins
by Na2CO3 treatment and osmotic shock. Proteomic analysis was performed on each of these fractions, allowing
us to confirm the presence of enzymes involved in various metabolic pathways as well as identify new com-
ponents of this parasite’s glycosomes.
1. Introduction
Whereas in almost all eukaryotic organisms glycolysis is a process
that occurs in the cytosol, in Kinetoplastea the major part of the
pathway is localized in organelles called glycosomes. The glycosomes of
T. cruzi contain the enzymes converting glucose into 3-phosphoglyce-
rate (3PGA); only the last three enzymes of the glycolytic pathway are
present in the cytosol [1,2]. A consequence of this organization is that,
inside these organelles, the ATP consumed by hexokinase (HK) and
phosphofructokinase (PFK) is regenerated by a phosphoglycerate kinase
(PGK) and, in two auxiliary branches of glycolysis, a phosphoenolpyr-
uvate carboxykinase (PEPCK) and/or pyruvate phosphate dikinase
(PPDK). The regeneration of ATP by PEPCK and/or PPDK implies that
entry of cytosolic PEP is absolutely necessary. Similarly, the NADH
formed in the reaction catalyzed by glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) is re-oxidized inside the organelles by re-
duction of oxalocetate (produced from PEP by PEPCK) to malate by a
glycosomal malate dehydrogenase (MDH) and in a subsequent reduc-
tion of fumarate produced from the malate to succinate by a soluble
NADH-dependent fumarate reductase (FRD) [3]. Another route that
may contribute to the regeneration of glycosomal NAD+ involves a
NAD-dependent glycerol-3-phosphate dehydrogenase (GPDH) [4] that
catalyzes the reduction of dihydroxyacetone phosphate (DHAP) to
glycerol 3-phosphate (Glyc3P). Subsequently, the electrons are trans-
ferred to oxygen via a mitochondrial electron-transport system and a
redox shuttle comprising a putative transporter in the glycosomal
membrane which exchanges Glyc3P for DHAP. The transporter remains
to be identified, but its existence is inferred from the requirement for
strict coupling of the fluxes by which the two triosephosphates are
exchanged. All glycosomal enzymes present high latency upon isolation
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of the organelles, which is in accordance with the notion that the gly-
cosomal membrane acts as a permeability barrier for the enzymes and
their cofactors, whereas it, like the membrane of peroxisomes in other
organisms, may allow passage of small metabolites through channels
[5–7]. In addition, another important pathway of glucose oxidation
present in glycosomes (as well as the cytosol) is the pentose-phosphate
pathway (PPP). The PPP usually has two major roles, namely the re-
duction of NADP+ to NADPH, as well as the production of ribose 5-
phosphate to be used as substrate for the synthesis of a variety of cell
components [8].
Besides glycolysis and the PPP, the presence of enzymes involved in
other metabolic routes has also been described for glycosomes of dif-
ferent trypanosomatids (T. cruzi, Trypanosoma brucei, Leishmania spp.):
gluconeogenesis, purine salvage, β-oxidation of fatty acids and bio-
synthesis of ether-lipids, isoprenoids, sterols and pyrimidines [9–14].
It has been observed that several of the enzymes belonging to these
pathways are essential for the survival of the bloodstream form of T.
brucei [15–17]. Therefore, some of these glycosomal enzymes are con-
sidered as potential pharmacological targets [14,18–20]. Glycosomes,
like peroxisomes contain peroxins (PEX proteins), proteins involved in
the different routes of the biogenesis of the organelles, such as the
import of proteins synthesized in the cytosol into the matrix of the
organelles [20]. Many, but not all, of the glycosomal matrix proteins
exhibit a peroxisomal-targeting signal (PTS) comprising a partially
conserved motif at their C-terminus or close to their N-terminal end,
called PTS1 or PTS2, respectively [17,19,21,22].
In the study reported in this paper, we have purified glycosomes from T.
cruzi and separated the soluble matrix from the membranes. Subsequently,
the proteins attached peripherally to the membrane were separated from
the integral membrane proteins through treatment with Na2CO3 and ex-
posure to an osmotic shock [23]. To obtain information about the growth-
dependent variation of the glycosomal membrane and soluble proteins, we
have chosen to compare glycosomes from exponentially growing epimas-
tigotes, whose metabolism is essentially glycolytic, with those from sta-
tionary-phase epimastigotes, in which the metabolism has shifted to cata-
bolism of amino acids as their carbon and energy source [24,25].
2. Materials and methods
2.1. Parasites culture
Trypanosoma cruzi epimastigotes (EP strain) were axenically culti-
vated in liver infusion-tryptose (LIT) medium at 28 °C as previously
described [26]. Cells were harvested when they reached the mid-ex-
ponential and stationary growth phase at OD600 nm values of 0.6 and
1.2, respectively.
2.2. Glycosome purification
The parasites (exponential and stationary phase) were centrifuged
at 800 x g for 10min at 4 °C, and washed twice with isotonic buffer A
(20mM Tris−HCl, pH 7.2 with 225mM sucrose, 20mM KCl, 10mM
KH2PO4, 5mM MgCl2, 1 mM Na2EDTA) and hypotonic buffer B (25mM
Tris−HCl, pH 7.6 with 250mM sucrose, 25mM NaCl, 1 mM Na2EDTA).
Homogenates of exponential and stationary phase parasites were ob-
tained by grinding washed cells with silicon carbide (200 mesh) in the
presence of a 1/100 (v/v) protease inhibitors cocktail (final con-
centrations: 1 μM pepstatin, 0.16 μM antipain, 5 μM leupeptin, 100 μM
tosyl leucine chloromethyl ketone, 2.8 μM trans-epoxysuccinyl-L-leu-
cylamido-(4-guanidino) butane (E-64), 100 μM sodium ethylene dia-
mine tetraacetate, 500 μM phenylmethyl sulfonylfluoride). Parasite
disruption was checked for being at least 90% complete by light mi-
croscopy. The homogenates were centrifuged first for 10min at 1000 x
g at 4 °C in order to remove silicon carbide, nuclei and intact cells. The
resulting supernatant was centrifuged for 20min at 5000×g at 4 °C to
remove a large granular fraction as a pellet. A small granular pellet
(glycosome-enriched fraction) was obtained after a centrifugation step
at 3000×g for 20min at 4 °C. This pellet was resuspended in 1.5ml of
buffer B containing a protease inhibitors cocktail and loaded on top of a
35ml linear 0.25–2.5M sucrose gradient. Centrifugation was per-
formed for 2 h at 170,000×g and 4 °C using a vertical rotor (Sorvall TV-
860). The glycosome-enriched fraction (1.21–1.25 g. cm−3) was applied
to a second sucrose gradient. Fractions of 1.9 ml were collected from
the bottom of the tube after puncture [23,27].
2.3. Isolation of glycosomal membrane proteins from T. cruzi epimastigotes
by sodium carbonate and osmotic shock treatment of the organelles
For the sodium carbonate or osmotic shock treatment, one volume
of the glycosomal fractions, with protein concentrations of 7mg. ml−1
and 5mg. ml−1 for the samples derived from the exponential and sta-
tionary growth phase, respectively, was mixed with about 100 volumes
of 100mM cold sodium carbonate (pH 11.5) or with cold milliQ water
according to [23,28] and incubated at 0 °C for 30min before ultra-
centrifugation at 105,000×g for 2 h at 4 °C. The pellet was homo-
genized in milliQ water with a potter and further centrifuged at
105,000×g for 2 h at 4 °C. This procedure allowed the separation of
matrix proteins and detached peripheral membrane proteins in the
supernatant and a membrane fraction with integral proteins in the
pellet after the sodium carbonate treatment and peripheral and integral
proteins in the pellet after the osmotic shock treatment. The protein
obtained in supernatants of sodium carbonate and osmotic shock
treatment were lyophilized in a Labconco freeze dryer and stored at
–80 °C until its later use.
2.4. Mass spectrometry analysis
Proteins were digested with trypsin using the FASP protocol as de-
scribed by [29]. Peptides were solubilized in 2% acetonitrile with 0.1%
trifluoro acetic acid and fractionated on a nanoflow uHPLC system
(Thermo ScientificRSLCnano) before online analysis by electrospray
ionisation (ESI) mass spectrometry on an Orbitrap Elite MS (Thermo
Scientific). Peptide separation was performed on a Pepmap C18 re-
versed phase column (Thermo Scientific). Peptides were desalted and
concentrated for 4min on a C18 trap column followed by an acetoni-
trile gradient (in 0.1% v/v formic acid) (3.2–32% v/v 4–27min, 32% to
80% v/v 27–36min, held at 80% v/v 36–41min and re-equilibrium at
3.2%) for a total time of 45min. A fixed solvent flow rate of 0.3 μl.
min−1 was used for the analytical column. The trap column solvent
flow was 25 μl. min−1 of 2% acetonitrile with 0.1% v/v trifluoroacetic
acid. Eluate was delivered online to the Orbitrap Elite MS (Thermo
Scientific), acquiring a continuous duty cycle of a high resolution pre-
cursor scan at 60,000 RP (at 400 m/z), while simultaneously acquiring
the top 20 precursors subjected to CID fragmentation in the linear ion
trap. Singly charged ions were excluded from selection, while selected
precursors are added to a dynamic exclusion list for 120 s. Protein
identifications were assigned using the Mascot search engine (v2.5.1) to
interrogate T. cruzi CL Brener protein coding sequences in the NCBI
database, allowing a mass tolerance of 10 ppm for the precursor and
0.6 Da MS/MS matching.
2.5. Bioinformatic analysis
To classify type-1 and type-2 peroxisomal targeting signals in the
glycosomal proteins revealed in this study, the [ASCGPNYTV]
[KNRHQDS][LMVAIF] motif was used to recognize proteins having the
PTS1 sequence, while the [RKHQ][VLIWFY]X5[HKQR][ILVYAF] se-
quence was used to identify proteins with the PTS2 sequence [30].
PTS1 and PTS2 containing sequences identified in our analysis were
searched in the TriTryp and GeneDB databases. A comparison was
made of the protein repertoires found in the glycosomes of epimasti-
gotes grown to exponential and stationary phases.
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2.6. Protein determination
Protein concentration was determined by the method of [31] using
the Bio-Rad Bradford protein assay.
2.7. Enzymatic assays
Hexokinase (HK) and glutamate dehydrogenase (GDH) activities
were assayed spectrophotometrically according to [32] and [33], re-
spectively. The activities were measured in a Hewlett-Packard 8452
diode array spectrophotometer at 340 nm at 28 °C, in the presence of
0.1% (v/v) Triton X-100 and 150mM NaCl in order to solubilize
membrane and eliminate latency.
3. Results and discussion
3.1. Glycosome purification and proteome analysis by mass spectrometry
Glycosomes were isolated from epimastigotes in exponential and
stationary growth phase by differential centrifugation followed by two
rounds of isopycnic ultracentrifugation on a sucrose gradient. Figure SI
(Supplementary Information) shows that most glycosomes were re-
covered in fractions corresponding to densities of 1.23 to 1.24 g. cm−3
(fractions 6 and 7) after the isopycnic ultracentrifugation (HK activity
was used as glycosomal marker). In contrast, most GDH, a mitochon-
drial marker enzyme, was recovered in fractions corresponding to
densities of 1.15 to 1.17 g. cm-3 (fractions 8–10). A small overlap of the
HK activity with that of GDH (in fractions 8–10) was observed, which
could be due to rupture of glycosomes during isolation. Analysis of the
HK and GDH activities showed that fractions 3 to 6 contained about
35% of the total HK activity measured, and only 5% of the total GDH
activity. For this reason, we decided to use fractions 3 to 6 for glyco-
somal membrane protein isolation by sodium carbonate and osmotic
shock treatment. The isolation procedures and the mass spectrometry
data acquisition using the samples are described in Materials and
methods, sections 2.3 and 2.4.
Studies with peroxisomes demonstrated the involvement of vesicles
derived from mitochondria as well as the endoplasmic reticulum in the
biogenesis of the organelles, implying that the classification of some
proteins as "contaminants" in a peroxisomal preparation must be care-
fully considered [34–36]. In this respect, we used three criteria to as-
sign proteins as authentic to glycosomes: (i) the results of our proteomic
analysis; (ii) the presence of a glycosomal import signal of type PTS1 or
PTS2; and (iii) previous publications about the association of proteins
with T. cruzi glycosomes and a comparison with the data reported in
proteomics studies of glycosomes from other kinetoplastids [22,37,38].
For this last criterion, special emphasis was placed on the work of [22]
with the organelles of procyclic T. brucei, because this latter study can
be considered as presenting a minimal level of contamination as a result
of the powerful epitope-tagged method of glycosome isolation used.
3.2. Glycolysis
The analysis of the glycosomal preparations showed the presence of
known and novel glycosomal matrix and membrane proteins, both in
exponentially growing parasites and cells grown to the stationary phase
(Tables SI-SVI). Based on the data obtained, we constructed schemes for
predicted glycosomal metabolic pathways of T. cruzi epimastigotes, as
shown in Figs. 1–4. Classical glycolytic enzymes (from HK to PGK) al-
ready previously reported [39,40] to be present in glycosomes of T.
cruzi were indeed detected in the proteomes of both exponential and
stationary phase cells (Fig. 1). Additionally, glucokinase, a glucose-
specific phosphorylating enzyme present in T. cruzi but not in T. brucei
was also detected, in agreement with its PTS1 motif (AQL) and sub-
cellular localization previously described [41]. An interesting case is
constituted by PGK, which in T. cruzi is encoded by three genes,
denominated PGK-A, PGK-B and PGK-C. Our previous studies showed
that all three isoforms of the enzyme are expressed in epimastigotes,
with both PGK-A and PGK-C present in glycosomes, the former one
being associated with the membrane, and the latter isoform located in
the matrix of the organelles [42]. Meanwhile, PGK-B is cytosolic and
accounts for 80% of the total cellular PGK activity [43]. Interestingly, in
the current analysis, three PGKs with different predicted molecular
weights (44.78, 64.87 and 100.44 kDa) were detected by the mass
analysis. The sequence of the 64.87 kDa PGK (accession code
Tc00.1047053511419.50) has a long extension of 85 amino acids at the
N-terminus. Analysis of this N-terminal extension with TMHMM soft-
ware [44] predicts two transmembrane helices (formed by residues 15
to 37 and 50 to 72), indicating that the sequence of this PGK form likely
corresponds with the previously reported 56 kDa membrane-associated
PGK-A isoenzyme [43,45]. The 44.78 kDa protein corresponds to the
previously identified 46 kDa PGK-C. Remarkably, an unusual PGK-like
protein of 100.44 kDa (Tc00.1047053504153.20) was found in the
pellet obtained by treatment of the glycosomal membrane preparation
with sodium carbonate. Using the TMHMM software, we could establish
in this PGK the presence of three candidate transmembrane helices.
These correspond to residues 745 to 767, 787 to 805 and 820 to 842 in
the C-terminal region. Also intriguing was the finding of two glyco-
somal PGK-like proteins of 58.4 kDa with a PAS domain
(Tc00.1047053506945.20 and Tc00.1047053506835.70). PAS do-
mains are important signaling modules that can monitor changes in
light, redox potential, oxygen, small ligands, and overall energy level of
a cell. These domains have been identified in proteins from all three
kingdoms of life: Bacteria, Archaea, and Eukarya [46–48]. This PGK-like
protein with a PAS domain was previously also found in an analysis of
glycosomal membrane proteins of Leishmania tarentolae [49].
3.3. Pentose-phosphate pathway
Enzymes of both the oxidative branch and the non-oxidative branch
of the PPP have been detected previously in glycosomes of the three
developmental forms of T. cruzi [50]. However, in our analysis, only
transaldolase was detected in the supernatant obtained after sodium
carbonate treatment of glycosomes from exponentially growing para-
sites. Intriguingly, we found sedoheptulose-1,7-bisphosphatase, having
the PTS1 motif SKL, in both exponential and stationary phase cells. This
enzyme has previously been predicted by genome analysis in T. cruzi
and T. brucei [51]. Sedoheptulose-1,7-bisphosphatase is a Calvin cycle
enzyme that is usually found in plastids of plants, algae, some fungi and
ciliates [52]. The presence of this enzyme suggests that possibly the
parasites employ this enzyme as part of a modified PPP (Fig. 3). Special
attention is deserved for the presence of a hypothetical protein
(Tc00.1047053511003.190) with a PTS1-like motif (SNL) that shows
similarity with glucose-6-phosphate-1-epimerases. Since glucose-6-
phosphate dehydrogenase is specific for β-D-glucose 6-phosphate
(G6P), the presence of a glucose-6-phosphate-1-epimerase might be
important for the PPP. This has been hypothesized by Gualdrón-López
et al. [13] for trypanosomatids, especially for T. brucei which lacks a
glucokinase gene. Glucokinase and hexokinases have each a preference
for distinct anomers of glucose, the beta and alpha anomer, respec-
tively. Although T. cruzi contains both enzymes, it cannot be ruled out
that glucose-6-phosphate-1-epimerase can also participate in the reg-
ulation of the interconversion rate between the G6P anomers inside the
glycosomes of T. cruzi [53].
3.4. Sugar-nucleotide synthesis
Several enzymes involved in the synthesis of sugar nucleotides
were detected in the glycosome preparations. First, two isoforms
of phosphomannose isomerase (Tc00.1047053503677.10 and
Tc00.1047053511717.90), both enzymes having a PTS1 motif (AHM
and AHI, respectively) and previously found to be essential for T. brucei
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growth [54]. The enzyme is involved in the reversible isomerization of
fructose 6-phosphate to mannose 6-phosphate.
Another enzyme detected is a phosphomanno mutase-like protein
(Tc00.1047053506405.10). This enzyme was previously found in gly-
cosomes of T. brucei and has the pecularity of acting as a phosphoglu-
comutase during glycolysis [49,55]. Other enzymes of the sugar-nu-
cleotide synthesis with PTS motifs were also found (Table SIII).
Synthesis of glycoconjugates requires a constant supply of sugar nu-
cleotides (NDP-sugars), molecules that are needed for parasite survival,
invasion and/or evasion of the host immune system [56]. Indeed, ga-
lactokinase (GALK), the first enzyme involved in the salvage pathway of
UDP-galactose was found associated with the glycosomal preparation.
It is present in T. cruzi but not in T. brucei, as two isoenzymes of
51–52 kDa, encoded by distinct genes (GALK-1 and GALK-2) both
having a PTS1 (SNL and GKL) [57].
3.5. Auxiliary pathways of carbon metabolism
Trypanosomatids contain enzymes for succinic fermentation,
forming an auxiliary branch to the glycolytic and gluconeogenic path-
ways. The branch contains PEPCK, malate dehydrogenase (MDH), fu-
marate hydratase (FH – also known as fumarase) and a soluble NADH-
dependent fumarate reductase (FRD) [3,58]. This branch was pre-
viously located in glycosomes of T. brucei [3]. Indeed the enzymes were
also detected in our T. cruzi glycosomal preparation (from both ex-
ponential and stationary phase cells). Noteworthy, the glycosomal
localization of one of the enzymes of the branch, FH, has been subject to
discussion; this enzyme appeared to be predominantly present in the
cytosol of T. brucei [3,37,59,60]. In addition, no authentic PTS motif
was found in FH, but the presence of a cryptic PTS1 at the C-terminal
extremity of T. brucei FH (AKLV), as well as in L. major FH (SKTLA) and
T. cruzi FH (SKLL) has been suggested as a possible explanation for a
dual localization in cytosol and glycosomes [61]. However, data from
our current study indicate that the FH of some T. cruzi strains indeed
possess a cryptic PTS1 (SKLL or SKLF), whereas in other strains such a
cryptic PTS1 is missing (the FH sequence ending in QQLK). Interest-
ingly, a potential PTS2 (KYVPLIPHV) was found near the N-terminus of
the FH lacking the cryptic PTS1 of these latter strains (e.g. in the pro-
duct of gene Tc00.1047053509879.40).
Another important auxiliary branch involves the enzyme PPDK that
may play a role in the adenine-nucleotide homeostasis inside glycosomes,
coupled to inorganic pyrophosphate (PPi) metabolism of trypanosomes.
PPDK as well as an adenylate kinase [12] were detected in our glycosomal
preparations. In T. cruzi epimastigotes a PPDK of 100 kDa can be post-
translationally modified by phosphorylation and proteolytic cleavage into
an inactive protein of 75 kDa. This modified form of PPDK was located
peripherally at the glycosomal membrane, oriented towards the cytosol
[23,62]. Meanwhile, three isoforms of adenylate kinase were detected in
the proteomic analysis. One of them (Tc00.1047053509733.180) con-
tains a PTS1-type sequence (CKL) at its C-terminus.
Interestingly, we identified two possible novel auxiliary routes for
the regeneration of NAD+ in glycosomes. First, a D-isomer specific 2-
Fig. 1. Carbohydrate metabolism. ●: Proteins
found in the mass analysis that present a PTS1
or PTS2 motif; ■: Proteins found in the mass
analysis but which do not present a PTS1 or
PTS2 sequence; ○: Proteins not detected in the
mass analysis but reported in literature. 1.
hexokinase, 2. glucokinase-1, 3. D-hexose-6-
phosphate-1-epimerase, 4. glucose-6-phos-
phate isomerase, 5. 6-phospho-1-fructokinase,
6. fructose-bisphosphate aldolase, 7. triose-
phosphate isomerase, 8. glyceraldehyde-3-
phosphate dehydrogenase, 9. phosphoglyce-
rate kinase, 10. enolase, 11. phosphoenolpyr-
uvate carboxykinase, 12. glycosomal malate
dehydrogenase, 13. fumarate hydratase, 14.
NADH-dependent fumarate reductase, 15.
pyruvate phosphate dikinase, 16. D-isomer
specific 2-hydroxyacid dehydrogenase-protein,
17. aldehyde dehydrogenase, 18. alcohol de-
hydrogenase, 19. glycerol-3-phosphate dehy-
drogenase, 20. glycerol kinase, 21. galactoki-
nase, 22. phosphomannomutase-like protein,
23. phosphomannose isomerase, 24. fructose-
1,6-bisphosphatase, 25. glucosamine-6-phos-
phate isomerase, 26. N-acetylglucosamine-6-
phosphate deacetylase-like protein, 27. glyce-
rate kinase (hypothetical protein), 28. 2-hy-
droxy-3-oxopropionate reductase, 29. UTP-
glucose-1-phosphate uridylyltransferase [22],
30. UDP-galactose 4-epimerase [21,125], 31.
UDP-sugar pyrophosphorylase [126], 32. GDP-
mannose pyrophosphorylase [127], 33. alanine
dehydrogenase [12], 34. phosphoglycerate
mutase [2], 35, pyruvate kinase [2]. G-6-P:
glucose 6-phosphate, G-1-P: glucose 1-phos-
phate, UDP-glc: UDP-glucose, UDP-gal: UDP-
galactose, Gal-1-P: galactose 1-phosphate,
GDP-gal: GDP-galactose, Mannose-1-P: man-
nose 1-phosphate, Mannose-6-P: mannose 6-
phosphate, F-6-P: fructose 6-phosphate, FBP:
fructose 1,6-bisphosphate, DHAP: dihydroxyacetone phosphate, GAP: glyceraldehyde 3-phosphate, Glyc-3-P: glycerol 3-phosphate, 1,3BPGA: 1,3-bispho-
sphoglycerate, 3-PGA: 3-phosphoglycerate, 2-PGA: 2-phosphoglycerate, PEP: phosphoenolpyruvate, OXAC: oxaloacetate.
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hydroxyacid dehydrogenase (α-HADH, EC 1.1.99.6); this enzyme is a
NAD-linked oxidoreductase whose catalytic properties resemble those
of mouse and rat LDH-C4. This enzyme has two molecular forms
(HADH-isozyme I and HADH-isozyme II). Isozyme I is responsible for
the weak lactate dehydrogenase activity found in T. cruzi extracts
[40,63,64] (Fig. 1, enzyme 16) and it might be an alternative for the
reoxidation of glycosomal NADH through the reduction of the pyruvate
produced by the PPDK.
The second enzyme potentially playing a role in glycosomal NAD+
regeneration is a PTS1-containing putative aldehyde dehydrogenase (EC
1.2.1.3) (Tc00.1047053507641.60) that could reduce and decarboxylate
pyruvate to acetaldehyde (Fig. 1, enzyme 17). This enzyme was detected
only in glycosomes from parasites in the exponential growth phase. Its
mammalian homolog has been described as part of the α-oxidation pro-
cess in peroxisomes catalyzing the oxidation of pristanal to pristanic acid
(which can enter the β-oxidation pathway) [65]. Additionally, the pre-
sence of these enzymes was also reported in the proteomic analysis of
purified glycosomes of T. brucei [22]. Interestingly, an enzyme detected in
both exponential and stationary phase glycosomes is
Tc00.1047053511277.60, belonging to a class of oxidoreductases that
can catalyze the reversible oxidation of ethanol to acetaldehyde (thus an
alcohol dehydrogenase, ADH) with the concomitant reduction of NAD
(P)+ (Fig. 1, enzyme 18). The presence of an ADH (also known as NADP-
aldehyde reductase) in T. cruzi has previously been described by Arauzo
and Cazzulo [66]; it was reported as a cytosolic enzyme. However, in
contrast to the putative aldehyde dehydrogenase, the HADH isoenzymes
and ADH do not present a PTS motif, nor have they been described by
Güther et al. [22] and Vertommen et al. [37] for the T. brucei glycosomal
proteomes. However, it should be noted that also no orthologs were de-
tectable in the T. brucei genome when searching TriTrypDB. Because of
the lack of a typical PTS, we cannot yet entirely exclude the possibility
that the two T. cruzi proteins represent a cytosolic or mitochondrial (a
potential mitochondrial signal peptide is predicted from the HADH-iso-
zyme I sequence) contamination of the glycosomal sample, but the pre-
sence of a possible internal glycosomal-targeting signal or import medi-
ated by a piggy-back mechanism through their association with other
glycosomal proteins remain options. These three enzymes could thus be
alternatives for regeneration of NAD+ when PEP is not available to follow
the branch PEPCK/MDH/FH/FRD. Since, however, this proposed role is
only based on bioinformatic analysis and in vitro assays, further studies
Fig. 2. Lipid metabolism.●: Proteins found in the mass analysis that present a PTS1 or PTS2 motif;■: Proteins found in the mass analysis but which do not present a
PTS1 or PTS2 sequence; ○: Proteins not detected in the mass analysis but reported in literature. 1. ABC transporter GAT1, 2. fatty-acyl CoA synthetase, 3. acyl-CoA
dehydrogenase, 4. enoyl-CoA hydratase, 5. 3-hydroxyacyl-CoA dehydrogenase, 6. 3-ketoacyl-CoA thiolase, 7. 3,2-trans-enoyl-CoA isomerase, 8. enoyl-CoA isomerase,
9. carnitine/choline O-acyltransferase, 10. fatty-acyl-CoA reductase, 11. alkyl-dihydroxyacetone phosphate synthase, 12. 3-hydroxy-3-methylglutaryl CoA synthase,
13. 3-hydroxy-3-methylglutaryl-CoA reductase, 14. mevalonate kinase, 15. isopentenyl-diphosphate delta-isomerase, 16. squalene monooxygenase, 17. lanosterol 14-
alpha-demethylase, 18. NAD(P)-dependent steroid dehydrogenase protein, 19. sterol 24-C-methyltransferase, 20. C-8 sterol isomerase, 21. sterol C-24 reductase, 22.
DHAP acyltransferase [74], 23. 1-alkyl G3P:NADP+ oxidoreductase [21,67], 24. squalene synthase [81]. DHAP: dihydroxyacetone phosphate, HMG-CoA: 3-hydroxy-
3-methylglutaryl-CoA.
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are required to determine how these enzymes are involved in the glyco-
somal intermediary metabolism of T. cruzi.
Additionally, enzymes involved in glycerol metabolism were also
detected in glycosomes from trypanosomes in both phases of growth:
glycerol-3-phosphate dehydrogenase, in agreement with our previous
report [4] and glycerol kinase, the latter having a PTS1 motif (AKL).
3.6. Ether-lipid biosynthesis
The initial evidence for identification of ether-lipid biosynthesis as a
glycosomal process was the finding that activity of the first two steps of
this pathway is associated with the organelles from procyclic forms of T.
brucei [67] and promastigotes of L. mexicana [68].
From the proteomic data obtained here on purified T. cruzi glyco-
somes we could determine the presence of alkyl-dihydroxyacetone
phosphate synthase (Tc00.1047053503815.10), the second enzyme of
the pathway (Fig. 2 and Tables SI and SIV). This enzyme, presenting a
PTS1 motif (SHL), has also been reported in glycosomes of other ki-
netoplastids [22,68,69]. Nevertheless, the enzymes catalyzing the first
and third step of this pathway, dihydroxyacetone phosphate acyl-
transferase and acyl/alkyl dihydroxyacetone phosphate reductase, also
reported in glycosomes of T. brucei and Leishmania spp. [67–70], were
not detected in the T. cruzi proteomic analysis.
3.7. Lipid metabolism
β-Oxidation is a catabolic pathway that has been located in per-
oxisomes and mitochondria. In glycosomes, this route has only been
reported in T. cruzi and T. brucei [12,71] and recently detected by
proteomics in glycosomes of T. brucei, L. donovani and L. tarentolae
[22,49]. According to our results, the T. cruzi glycosomes contain all
enzymes involved in the β-oxidation, in both the exponential and sta-
tionary growth phase, and each of the sequences has a PTS1 or PTS2
(Fig. 2 and Table SI and SIV). We found two isoforms homologous to the
trifunctional enzyme enoyl-CoA hydratase/enoyl-CoA isomerase/3-hy-
droxyacyl-CoA dehydrogenase (EC 4.2.1.17/5.3.3.8/1.1.1.35)
(Tc00.1047053507547.40 and Tc00.1047053508441.70), both con-
taining a PTS2 (RVDTILSHV), whereas the 3-ketoacyl-CoA thiolase
(Tc00.1047053509463.30) presents a PTS1-like sequence (ANI).
An acyl-CoA-binding protein (ACBP) (Tc00.1047053510877.55)
also detected in the T. cruzi glycosomal proteome shows a typical PTS1
(SKL). It was previously also found in the high-confidence proteomic
analysis of T. brucei glycosomes [22]. ACBP binds medium- and long-
chain acyl-CoA esters and has been reported to be essential in blood-
stream-form T. brucei [72].
3.8. Purine and pyrimidine synthesis
While mammalian cells can synthesize purines de novo, protist
parasites including T. cruzi and other trypanosomatids such as T.
brucei and Leishmania spp. have to recycle them through the purine
salvage pathway for the synthesis of AMP and GMP [73,74] (Fig. 3). In
our proteomic analysis, three enzymes of the purine salvage pathway
were detected: adenine phosphoribosyltransferase (APRT), hypox-
anthine-guanine phosphoribosyltransferase (HGPRT) and inosine-5′-
monophosphate dehydrogenase (IMPDH). For APRT, four isoenzymes
Fig. 3. Purine salvage, pyrimidine biosynthesis
and pentose-phosphate pathway. ●: Proteins
found in the mass analysis that present a PTS1
or PTS2 motif; ○: Proteins not detected in the
mass analysis but reported in literature.1.
hexokinase, 2. glucokinase 1, 3. D-hexose-6-
phosphate-1-epimerase, 4. ribulokinase, 5. ri-
bokinase, 6. transaldolase, 7. sedoheptulose-
1,7-bisphosphatase, 8. phosphoribosylpyr-
ophosphate synthetase (hypothetical protein),
9. nucleoside phosphorylase, 10. adenine
phosphoribosyltransferase, 11. AMP deami-
nase, 12. inosine-5′-monophosphate dehy-
drogenase, 13. guanosine monophosphate re-
ductase, 14. hypoxanthine-guanine
phosphoribosyltransferase, 15. orotate phos-
phoribosyltransferase, 16. orotidine-5-phos-
phate decarboxylase, 17. dihydroxyacetone
kinase, 18. phosphopentomutase, 19. dihy-
droxyacetone synthase [128], 20. glucose-6-
phosphate dehydrogenase [50], 21. lactonase
[50], 22. 6-phosphogluconate dehydrogenase
[129], 23. ribulose-5-phosphate epimerase
[130], 24. ribulose-5-phosphate isomerase
[50], 25. transketolase [50]; 26. sedoheptu-
lose-1,7-phosphate transaldolase [21]. G-6-P:
glucose 6-phosphate, R-5-P: ribulose 5-phos-
phate, Ribo-5-P: ribose 5-phosphate, Xyl-5-P:
xylulose 5-phosphate, GAP: glyceraldehyde 3-
phosphate, F-6-P: fructose 6-phosphate, DHA:
dihydroxyacetone, DHAP: dihydroxyacetone
phosphate, Ery-4-P: erytrose 4-phosphate, S-
1,7BP: sedoheptulose 1,7-bisphosphate,
HCHO: acetaldehyde, GMP: guanosine mono-
phosphate, AMP: adenosine monophosphate,
IMP: inosine monophosphate, XMP: xanthosine
monophosphate, OMP: orotidine monopho-
sphate, UMP: uridine monophosphate.
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were identified, all with a PTS1 motif (Tc00.1047053507519.150,
Tc00.1047053508207.70, Tc00.1047053507519.140 and
Tc00.1047053508207.74). The mass analysis detected also four iso-
enzymes of HGPRT (EC 2.4.2.8) (Tc00.1047053506457.40,
Tc00.1047053509693.80, Tc00.1047053509693.70 and
Tc00.1047053506457.30), but only two of them showed a PTS1
(AHL). For IMPDH the mass analysis indicated the presence of two
isoforms (Tc00.1047053507211.40 and Tc00.1047053511301.110)
which have high (98%) sequence identity and an unequivocal PTS1
(SKL). Additionally, two isoenzymes of guanosine monophosphate
reductase (EC 1.7.1.7) were detected in the glycosomal fraction
(Tc00.1047053506519.130 and Tc00.1047053508909.20), both with
a PTS1 (SKL). Importantly, these enzymes have also been detected in
the proteomic analysis of T. brucei glycosomes [22] (Table SI).
The nucleotide salvage pathway provides an alternative that is en-
ergetically more efficient than de novo synthesis for the parasites. AMP
deaminase, which interconverts AMP and IMP, was also found in T.
cruzi glycosomes and this enzyme contains a PTS1 (SRL). Similarly, this
enzyme was detected in glycosome proteomic studies of other trypa-
nosomes [22].
Unlike the situation for purines, de novo synthesis of pyrimidines is
performed by trypanosomatids. In contrast to mammalian cells, de novo
synthesis of UMP in glycosomes involves two enzymatic steps: by or-
otate phosphoribosyltransferase and orotidine-5-phosphate decarbox-
ylase. These two activities are carried out by a bifuctional enzyme with
a C-terminal SKL motif encoded by a single fused gene [9,75]. The
activities were found to be associated with the glycosomes of T. brucei
and the organellar localization was confirmed in proteomic studies
[60,76]. In our analysis of T. cruzi glycosomes, two isoforms of the
bifunctional orotate phosphoribosyltransferase/orotidine-5-phosphate
decarboxylase enzyme were detected, with predicted molecular weights
of 29 and 50 kDa, respectively, but only the latter one showed the
classical PTS1 (SKL).
Additionally, a hypothetical protein (Tc00.1047053504147.10)
detected in the mass analysis showed 98% identity with a protein
putatively annotated in the TriTryp database as a
phosphoribosylpyrophosphate synthetase present in other strains of T.
cruzi (TCSYLVIO_004767 and MOQ_001239).
3.9. Sterol synthesis pathway
The sterol synthesis pathway, also known as the isoprenoid
pathway, is an essential metabolic pathway present in eukaryotes, ar-
chaea, and some bacteria. Interestingly, peroxisomes of eukaryotes
contain a set of enzymes involved in cholesterol biosynthesis that pre-
viously were considered to be cytosolic or associated with the en-
doplasmic reticulum. Moreover, some of them contain a conserved
putative PTS1 or PTS2, supporting the notion of targeted transport into
peroxisomes [77].
Our analysis detected, associated with glycosomes, a 55 kDa hy-
pothetical protein (Tc00.1047053511903.40) that shows similarity
with 3-hydroxy-3-methyl-glutaryl Coenzyme A (HMG-CoA) synthase.
HMG-CoA synthase, catalyzing the first step of the mevalonate
pathway, was previously located in peroxisomes [78,79]. Another key
enzyme located in glycosomes is HMG-CoA reductase, which is con-
sistent with our previous report where 80% of the activity of this en-
zyme was associated with glycosomes [27]. The next enzyme of this
pathway, mevalonate kinase, has been shown to be almost exclusively
located in glycosomes of T. brucei and L. major [80] and, in the pro-
teomic analysis of T. brucei, reported with high confidence as a glyco-
somal protein [22]. In our analysis, this enzyme is present as two iso-
forms (Tc00.1047053436521.9 and Tc00.1047053509237.10), but
only the latter possesses a PTS1 motif (AKI). Other enzymes of the
pathway, such as isopentenyl-diphosphate Δ-isomerase (EC 5.3.3.2)
(Tc00.1047053510431.10 and Tc00.1047053408799.19), squalene
monooxygenase (Tc00.1047053509589.20), lanosterol 14-α-demethy-
lase (Tc00.1047053506297.260), NAD(P)-dependent steroid dehy-
drogenase protein (Tc00.1047053510873.10), sterol 24-C-methyl-
transferase (Tc00.1047053505683.10), C-8 sterol isomerase
(Tc00.1047053510329.90) and sterol C-24 reductase (EC 1.3.1.71)
(Tc00.1047053507709.90) were also detected (Table SI and SIV). Of
these enzymes, only isopentenyl-diphosphate Δ-isomerase and C-8
Fig. 4. Glycosome membrane proteins detected or proposed. 1. Dimer of two half-size ABC transporters, 2. Peroxins, 3. Pore-forming proteins, 4. Proteins related to
the mitochondrial carrier family (MCF).
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sterol isomerase were detected in proteomic analyses of glycosomes
purified from procyclic-form T. brucei [22] and only isopentenyl-di-
phosphate Δ-isomerase, squalene monooxygenase and C-8 sterol iso-
merase present PTS1 or PTS2 motifs. Interestingly, HMG-CoA re-
ductase, squalene synthase [27,81], sterol 24-C-methyltransferase and
mevalonate kinase were already previously reported as enzymes of the
mevalonate pathway present in glycosomes of trypanosomes [60,82]. It
should be noted that in analysis of peroxisomes from mammals, phos-
phomevalonate kinase [83], isopentenyl diphosphate isomerase [84],
acetoacetyl-CoA thiolase [85], HMG-CoA synthase [79], HMG-CoA re-
ductase [86], mevalonate kinase [87], mevalonate diphosphate dec-
arboxylase [83], and farnesyl diphosphate synthase [88] were all found
to possess a PTS motif and their peroxisomal localization has been
determined experimentally. Interestingly, the acetoacetyl-CoA thiolase
(EC 2.3.1.9) from mammals that condenses two molecules of acetyl-
CoA to give acetoacetyl-CoA, contains both a mitochondrial signal
peptide at the amino terminus and a PTS1 at the carboxy terminus [79].
In our mass analysis, we detected the presence of several of the enzymes
involved in this anabolic pathway (Fig. 2); some of them have a clear
PTS1 motif, but others showed neither a PTS1 or PTS2. The presence of
these latter enzymes in glycosomes may be attributed to the existence of
non-consensus targeting sequences or piggy-back transport.
3.10. Detoxification of oxygen radicals
Iron-dependent superoxide dismutase (SOD) is an enzyme involved
in the dismutation of the highly reactive, toxic superoxide radical with
the formation of hydrogen peroxide (H2O2). It has been detected in
various kinetoplastids [89]. Four distinct SOD activities (SOD I, II, III,
and IV) have been characterized in the epimastigote form of T. cruzi and
selective membrane permeabilization with digitonin showed that these
SODs are primarily cytosolic, with small amounts associated to glyco-
somes (SOD I and II of 20 and 60 kDa, respectively) and mitochondrion
(SOD III of 50 kDa) [90]. In our proteomic analysis two Fe-SODs of
23.5 kDa were identified (Tc00.1047053508445.20 and
Tc00.1047053511715.10) (Table SI). Their presence and location are
consistent with the glycosomal proteome of procyclic T. brucei [22,60],
and previous reports about the characterization of these isoenzymes in
T. brucei [91,92].
Additionally, two isoenzymes of tryparedoxin peroxidase were de-
tected in the glycosomal fraction (Tc00.1047053487507.10 and
Tc00.1047053509499.14). These enzymes participate in decomposing
H2O2 using electrons donated either directly from trypanothione, or via
the redox intermediate tryparedoxin. Is important to mention the de-
tection of a glutathione peroxidase-like protein
(Tc00.1047053503899.130) with a PTS2 motif in the glycosomal mass
analysis that could contribute to this process. Tryparedoxin
(Tc00.1047053509997.30), having a predicted PTS2, was also detected
in the analysis. Additionally, this protein was reported in the glyco-
somal proteome of T. brucei (Tb927.3.3760) [22]. The flavoprotein
trypanothione reductase is a key enzyme in the antioxidant metabolism
of trypanosomes and represents a potential drug target. This enzyme
from various kinetoplastid parasites has been characterized in detail
[93–95]. In our analysis two isoenzymes of 42 and 54 kDa were de-
tected (Tc00.1047053504507.5 and Tc00.1047053503555.30, respec-
tively) with the latter presenting a PTS1 (ASL). The presence of this
enzyme in glycosomes is corroborated by the glycosomal proteome of T.
brucei [22].
3.11. Gluconeogenesis
Two fructose-1,6-bisphosphatase (FBPase) isoforms were detected
in the proteomic analysis of T. cruzi glycosomes
(Tc00.1047053506649.70 and Tc00.1047053508351.10); they show
98% sequence identity and have both a classical PTS1 (SKL). This is a
hallmark enzyme of gluconeogenesis whose presence was previously
reported in an extract of epimastigotes of T. cruzi and in the proteomic
analyses of glycosomes of T. brucei and L. donovani [22,96]. Interest-
ingly, FBPase and PFK can be expressed simultaneously in glycosomes
of T. cruzi and other kinetoplastids, potentially so creating a futile cycle
causing loss of ATP. However, activating the FBPase may also function
to partially re-direct the glucose 6-phosphate from glycolysis to the
PPP, as has been shown in Toxoplasma and hypothesized for Leishmania
[97]. Nonetheless, studies with T. brucei are suggestive of a reciprocal
regulation in the activities of these enzymes possibly by post-transla-
tional modification.
3.12. Transporters/integral membrane proteins
In peroxisomal membranes various types of transporters have been
described: peroxins, half-size ABC transporters, pore-forming proteins
and proteins of the mitochondrial carrier family (MCF). More recently
peroxins and ABC transporters have also been identified in glycosomal
membranes, and the existence of pore-forming proteins was also es-
tablished, however the identity of these latter proteins remains to be
established [6].
Peroxins (also known with the acronym PEX) are a group of proteins
involved peroxisome biogenesis, including the process of matrix-protein
import [98]. Most of them are integral or peripheral membrane pro-
teins, whereas some are soluble cytosolic proteins, either permanently
or transiently interacting with the membrane. For trypanosomatids,
peroxins have been studied in detail in T. brucei [20] and several of
them were also identified in its glycosomal proteome [22]. In our
proteomic analysis of T. cruzi purified glycosomes, we also detected
several PEX proteins (Table SI). First, peroxins implicated in matrix
protein import such as PEX2 (Tc00.1047053508479.230), PEX10
(Tc00.1047053508479.190), PEX12 (Tc00.1047053503809.20) were
detected in the pellet fraction of glycosomes treated by osmotic shock
and with Na2CO3. PEX14 (Tc00.1047053511145.40) was equally de-
tected in the pellet fraction of glycosomes treated by osmotic shock. A
search for proteins that align with the sequence of
Tc00.1047053503811.40 detected in the pellet of the Na2CO3 treated
glycosomes, showed 75% identity with the PTS2 receptor PEX7 of T.
brucei (Tb03.28C22.1010) [99].
Other integral membrane proteins that were detected are a pro-
tein annotated as (Tc00.1047053510043.40) that presents 33%
identity with T. brucei PEX16 [100], i.e. a peroxin involved in in-
sertion of peroxisomal membrane proteins (PMPs), as well as
homologs of T. brucei PEX11 (Tc00.1047053504005.40) and GIM5A
(Tc00.1047053507009.10) that is related to PEX11 [101]. PEX11 is
known to be involved in the morphology establishment and pro-
liferation of peroxisomes, but has also been identified, in yeast, as a
pore-forming protein [102].
The second group of known transporters in the glycosomal mem-
brane of T. brucei comprises three homologs of peroxisomal half-size
ABC transporters designated GAT1-3 (for glycosomal ABC transporters
1 to 3) [103]. Only for GAT1 a function has been shown, i.e. the
transport of acyl-CoAs from the cytosol into the glycosomal lumen
[104]. The function of GAT2 and GAT3 has not yet been established.
Interestingly, in the membrane fraction of T. cruzi glycosomes treated
with Na2CO3, various ABC transporters were detected (Tables SI and
SVI). Three ABC transporters show a considerably high identity with
GAT1, 2 and 3 of T. brucei. The protein (Tc00.1047053508927.20),
annotated as a hypothetical glycosomal transporter in the database,
shows 49% identity with TbGAT1 (Tb927.4.4050), whereas the other
ABC transporters detected (Tc00.1047053510431.150 and
Tc00.1047053506925.530) show 52% and 54% identity with GAT2
(Tb11.02.0630) and GAT3 (Tb11.03.0030) of T. brucei, respectively.
The three proteins were also reported with a high confidence as gly-
cosomal proteins in the T. brucei proteomics analysis [22].
As a third group of molecules involved in the transport of metabo-
lites through the peroxisomal and glycosomal membrane are pore-
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forming proteins. Such pores have been well characterized for peroxi-
somes, notably from mammalian cells and, besides PEX11, one other
pore-forming protein has been identified [105]. The sizes of the per-
oxisomal pores have been determined electrophysiologically and will
allow permeation of molecules with a Mr up to about 300–400 Da.
Furthermore, three main channel-forming activities were detected in
membranes of the glycosomal fraction from bloodstream-form T. brucei
permitting currents with amplitudes 70–80 pA, 20–25 pA, and 8–11 pA,
respectively [5]. In analogy to the situation in peroxisomes, it has been
proposed that such pores would allow the glycosome entry or exit of
metabolites of low molecular masses such as inorganic ions including
phosphate, PPi, glucose, G6P, oxaloacetate, malate, succinate, PEP, 1,3-
bisphosphoglycerate, 3PGA, DHAP, Glyc3P, etc., but not larger mole-
cules such as ATP, ADP, NAD(P)+, NADH(P), CoA, and fatty acids or
acyl-CoAs [5,105].
In our glycosome analysis, two proteins (Tc00.1047053509197.20
and Tc00.1047053508699.130) were identified as cation transporters
(Table SI). However, for the first one, no additional report is available
as yet to confirm it being localized in glycosomes, whereas the second
protein was previously identified as part of the contractile vacuole
complex of T. cruzi [106] and may thus have been a contamination in
the glycosomal fraction.
In addition, a transporter protein involved in maintaining the redox
balance within glycosomes through a Glyc3P/DHAP shuttle-based me-
chanism has not yet been described but its existence is presumed
[1,107]. Translocation of amino acids across the glycosomal membrane
is also necessary; it is likely that amino acids could diffuse through the
glycosomal pores. Nonetheless, the plasma-membrane arginine trans-
porter AAP3 has, under certain culturing conditions, also been detected
in the membrane of Leishmania glycosomes [108,109].
As shown in Tables S1 and SVI, two proteins
(Tc00.1047053508551.39 and Tc00.1047053506355.10) were found
in the pellet fraction obtained after carbonate treatment of glycosomal
membranes. Their sequences are identical to that of TcHT, previously
identified as the plasma-membrane glucose transporter by Silber et al.,
2009 [110]. Intriguingly, based on their immunolocalization studies,
these authors reported the association of this transporter also with
glycosomes and reservosomes. However, the functionality of TcHT as a
hexose transporter in the glycosomal membrane seems doubtful, not
only because so far no evidence has been found for functional trans-
porters for small (< 400 Da) solutes in the membrane of peroxisome-
related organelles of any organism – the current notion is that trans-
location occurs via channels – but also because membrane insertion of
proteins of plasma-membrane and peroxisomes/glycosomes is known to
occur by distinct mechanisms, involving specific topogenic signals and
proteins. Even when similar proteins would be routed to these different
destinations after insertion into the endoplasmic reticulum membrane,
they would have opposite topologies in the plasma membrane and
glycosomal membrane. Additionally, it would be difficult to imagine
how, in view of the different extra- and intracellular glucose con-
centrations, transport of this substrate across the different membranes
would be mediated by carriers with identical kinetic properties. A
possible explanation for the finding of TcHT also in intracellular
membranes is a non-specific association of excess transporter molecules
with hydrophobic environments, either directly with organellar mem-
branes or after association with the specific domains of the endoplasmic
reticulum destined to be routed to proliferating glycosomes. This same
explanation may be invoked for the Leishmania arginine plasma-mem-
brane transporter AAP3 that, under certain conditions is also found
associated with glycosomes as mentioned above.
Previously, a protein profile of glycosomal membranes from T. cruzi
epimastigotes revealed a most abundant protein of 75 kDa which was
later identified as PPDK [23,62]. This protein was initially detected in
the glycosomal membrane pellet obtained after treatment with Na2CO3,
but also in the soluble phase confirming its dual location in both the
membrane and the glycosomal matrix [23]. Interestingly, the PPDK
associated to the glycosomal membrane (75 kDa) appeared to be post-
translationally modified by phosphorylation and proteolytic cleavage
[62]. Moreover, studies of T. cruzi epimastigotes permeabilized with
digitonin and incubated with anti-PPDK showed significant inhibition
of glucose consumption when PEP was included in the assay. This result
may indicate the participation of the 75 kDa form of PPDK in the entry
of PEP into glycosomes (our unpublished results).
Several studies have indicated that T. brucei HK has a strong ten-
dency to remain associated with the glycosomal membrane [20]. Some
authors even suggested that the entry of glucose into the glycosomes
and the association of HK to the glycosomal membrane might be
functionally linked. Interestingly, oligomycin inhibits the linkage via a
mechanism that appeared not to be correlated to the energy charge of
the cell [111]. In addition, our experience in the purification of T. cruzi
HK showed that when a glycosome-enriched fraction was treated with
80% ammonium sulfate (saturated concentration), the enzyme’s ac-
tivity was recovered as a flocculate floating on the solution (no protein
pellet was ever observed at this stage) [112]. This latter observation
would support the notion that HK of T. cruzi might be associated with
insoluble regions of the membrane, possibly in association with a pore
as has been proposed [20]. Further support for the hypothesis is the
detection, in our mass analysis, of HK in both the soluble fractions and
the pellets obtained after treatment with Na2CO3 and osmotic shock.
Other evidence that might suggest a close association between some
enzymes and glycosomal transporters or pores results from studies
performed on isolated glycosomes. In these studies the glycosomal la-
tency values of enzymes showed some inconsistencies. For example,
assays performed on glycosomes from T. cruzi and T. brucei showed high
latency for HK (between 77–80%), whereas in these same preparations
PGK showed only very low or no latency (3–50%) [2,113], our un-
published results]. A reinterpretation of these data could be that the
glycosomal PGK is tightly associated with the membrane, for example
forming a complex with a pore to facilitate specifically the translocation
of 3PGA between the glycosomal matrix and the cytosol.
A third group of peroxisomal membrane proteins is formed by some
MCF representatives [114–116]. Three different proteins of this family
have been reported in the glycosomal proteome of T. brucei [22,61].
These are homologs of transporters of phosphate, dicarboxylates and
ATP/ADP exchange. However, the unambiguous localization of MCF
transporters in glycosomes and the assignment of substrate specificity
for such transporters in general and trypanosomes in particular is not
always evident as shown in functional studies [117]. Nonetheless, a
MCF transporter with broad specificity for different, bulky compounds
such as ATP, ADP, AMP, CoA and NAD+ has been identified in human,
yeast and plant peroxisomes [116,118–122]. In our mass analysis we
detected homologs of a mitochondrial phosphate transporter
(Tc00.1047053509551.30) as well as an ADP/ATP mitochondrial car-
rier protein (Tc00.1047053511249.10) which have high identity (close
to 85%) with a protein annotated as mitochondrial carrier protein 11
(Tb09.211.1750) and ADP/ATP mitochondrial translocase
(Tb927.7.3940), respectively, in the T. brucei genome database. How-
ever, the functions of these proteins in T. brucei have not yet been
proved. Interestingly, both proteins were reported as high-confidence
glycosomal proteins in the proteomic analysis of T. brucei [22]. The
ADP/ATP mitochondrial carrier homolog of T. cruzi presents a putative
mitochondrial carrier sequence signature as well as the non-canonical
mitochondrial ATP/ADP motif sequence RRRMMM. It is attractive to
speculate that this protein, if (also) present in the glycosomal mem-
brane, could provide additional ATP necessary for intra-glycosomal
biosynthetic processes when the PGK and PEPCK would not be able to
provide it. In contrast to other antiport systems, the ADP/ATP trans-
locase is an electrogenic antiporter exchanging ATP that has four ne-
gative charges against ADP with only three, resulting in the net trans-
location of a negative charge. This translocator has been characterized
in the inner mitochondrial membrane where the electrochemical proton
gradient is the driving force for the exchange of ATP and ADP. In the
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case of glycosomes such translocator would be expected to act in most
instances to import ATP – thus in the opposite direction of its normal
mitochondrial function (although as shown for the T. brucei mi-
tochondrion, it can be reversed under certain conditions [123] and the
output of inorganic phosphate would be essential.
Another protein found is a homolog of a tricarboxylate carrier
(Tc00.1047053511583.40) of 36.2 kDa. A homolog has also been de-
tected by proteomic analysis of the glycosomal membrane of T. brucei
(Tb927.9.4310) and L. tarentolae (LtaP01.0560) [49]. This putative
tricarboxylate carrier of T. cruzi showed 69% and 56% identity with the
corresponding protein of T. brucei and L. tarentolae, respectively. Fur-
thermore, we detected a protein (Tc00.1047053506773.90) of 51 kDa
with 62% identity with a putative amino-acid permease/transporter of
T. brucei (Tb11.02.4520) and two other candidate amino-acid trans-
porters (Tc00.1047053506153.10 and Tc00.1047053507585.10), each
possessing 11 predicted transmembrane helices.
It should be realized that for many of the glycosomal membrane
proteins, whether integral or peripheral, identified in the proteome
analyses of both T. cruzi and other trypanosomatids, further studies will
be required to prove unambiguously that they are authentic glycosomal
(or shared between glycososomal and other membranes such as that of
the mitochondrion) and not contaminants in the glycosomal fractions
analyzed. Moreover, functional studies to prove the identities of the
membrane proteins have only been performed for the peroxins (mostly
for T. brucei, to a lesser extent for Leishmania spp.) and one of the T.
brucei ABC transporters (GAT1). For all other proteins discussed above,
the possible functional identity is predicted from homology with mo-
lecules in non-trypanosomatid organisms. However, it is important to
realize that glycosomes have a very different metabolic repertoire than
peroxisomes of other organisms, so they need different metabolite
transporters. Trypanosomatids may have achieved this by recruiting
appropriate transporters from the available repertoire in other mem-
branes such as the mitochondrial inner membrane and/or by changing
the substrate specificity of transporters inherited from the peroxisomes
that evolved into glycosomes [5]. Functions assigned solely based on
sequence comparison should therefore be considered as tentative and
require confirmation by future functional studies.
3.13. Hypothetical proteins detected in association with glycosomes
A variety of other proteins bearing a classical PTS1 but with un-
known function were detected in our proteomic analysis (Table SII).
Several of these proteins present high identity with hypothetical pro-
teins identified with high confidence as glycosomal proteins in the
proteomic analysis of T. brucei [22]. Moreover, using a transmembrane
domains predictor TMHMM software, we could establish that several of
these hypothetical proteins present potential transmembrane alpha-
helical segments. These proteins have a variable number of alpha-he-
lices, ranging between one and 17 (Table SII). This characteristic sug-
gests that these proteins, passing several times through the membrane,
might fulfill the function of channels or transporters of important ions
or molecules involved in the metabolism occurring within glycosomes.
An interesting finding is the presence of a protein with 58.9%
identity to the T. brucei serine/threonine phosphatase PIP39 (Table SVI;
Tc00.1047053509353.40). Moreover, it has an identical PTS1 as
TbPIP39 (SRL). TbPIP39 is part of a protein phosphatase cascade that
regulates differentiation between the parasite’s developmental forms
[124]. Prior to the trigger for differentiation, TbPIP39 is kept in-
activated in a cytosolic assembly with the tyrosine phosphatase
TbPTP1, that dephosphorylates it. Upon the differentiation trigger – the
uptake of citrate from the blood into the trypanosome – the PTP1/
PIP39 complex is disrupted and PIP39 becomes phosphorylated and
activated and is translocated to the glycosomes. Future studies may
reveal if PIP39 and glycosomes are also involved in life-cycle differ-
entiation of T. cruzi.
4. Concluding remarks
In this manuscript we have presented insight into the different
biochemical processes that are carried out in the glycosomes of T. cruzi
epimastigotes through a proteomic analysis of a purified fraction con-
taining this organelle from cells grown to an exponential and stationary
phase. The intraglycosomal enzymatic equipment and the proteins
present in the glycosomal membrane reveal low variations between
these two growth phases of T. cruzi epimastigotes indicating that the
protein composition of this organelle is – at least in a qualitative sense –
largely independent of the carbon source. In addition to known glyco-
somal routes, we have found new glycosomal constituents which were
identified by electrospray ionization mass spectrometry (ESI) in an
Orbitrap Elite MS (Thermo Scientific).
These results provide information on possible new metabolic path-
ways in the organelles, as well as the identification of proteins possibly
present in the glycosomal membrane that could fill the void of solute
translocation mechanisms necessary for metabolism within the glyco-
somes. Several enzymes were found that had not yet been reported as
glycosomal but have motifs such as PTS1 and PTS2, e.g. aldehyde de-
hydrogenase, PAS-domain containing PGK, nucleoside diphosphate ki-
nase, arginine kinase, ribokinase, L-ribulokinase, sedoheptulose-1,7-
bisphosphatase, dihydroxyacetone kinase 1-like protein, and phos-
phoribosylpyrophosphate synthetase. To corroborate the glycosomal
localization of the new components identified in this study, it is ne-
cessary to carry out complementary experiments such as im-
munolocalization as well as others that allow to clarify the presence of
the respective enzymes.
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